Cargando…

RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice

Kidney cancer incidences are rising globally, thereby fueling the demand for targeted therapies and precision medicine. In our previous work, we have identified and characterized the Ras-Association Domain Family encoding ten members that are often aberrantly expressed in human cancers. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Antje M., Woods, Michelle L., Küster, Miriam M., Walesch, Sara K., Braun, Thomas, Boettger, Thomas, Dammann, Reinhard H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142015/ https://www.ncbi.nlm.nih.gov/pubmed/32047266 http://dx.doi.org/10.1038/s41388-020-1195-6

Ejemplares similares

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
por: Richter, A M, et al.
Publicado: (2012)

RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer
por: Richter, Antje M., et al.
Publicado: (2019)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
por: Jiménez, Adriana P., et al.
Publicado: (2017)

The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms
por: Haag, Tanja, et al.
Publicado: (2014)

Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer
por: Dammann, Reinhard H., et al.
Publicado: (2017)

Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma
por: Richter, Antje M., et al.
Publicado: (2013)

Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi
por: Walesch, Sara K., et al.
Publicado: (2015)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
por: Küster, Miriam M., et al.
Publicado: (2020)

The SARAH Domain of RASSF1A and Its Tumor Suppressor Function
por: Dittfeld, Claudia, et al.
Publicado: (2012)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
por: Richter, Antje M., et al.
Publicado: (2017)

Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
por: Deutschmeyer, Verena, et al.
Publicado: (2019)

ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth
por: Kiehl, Steffen, et al.
Publicado: (2014)

Epigenetically inactivated RASSF1A as a tumor biomarker
por: Raos, Dora, et al.
Publicado: (2021)

Promoter Methylation Status of Ras-Association Domain Family Members in Pheochromocytoma
por: Richter, Antje M., et al.
Publicado: (2015)

Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner
por: Woods, Michelle L., et al.
Publicado: (2022)

The cellular functions of RASSF1A and its inactivation in prostate cancer
por: Amin, Karishma S., et al.
Publicado: (2012)

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours
por: Cooper, WN, et al.
Publicado: (2008)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
por: Lázcoz, Paula, et al.
Publicado: (2006)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin
por: Yaqinuddin, Ahmed, et al.
Publicado: (2013)

Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma
por: Calvisi, Diego F., et al.
Publicado: (2012)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms
por: Haag, Tanja, et al.
Publicado: (2016)

Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis
por: Hansen, Sarah A., et al.
Publicado: (2016)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

PCDH18 is frequently inactivated by promoter methylation in colorectal cancer
por: Zhou, Dan, et al.
Publicado: (2017)

RASSF1A and the Taxol Response in Ovarian Cancer
por: Kassler, Susannah, et al.
Publicado: (2012)

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
por: Wiesmann, Frank, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_u4lgvha5gjkqctgiao9sbjedsb